More than a billion people taking statins? Potential implications of the new cardiovascular guidelines

JAMA

Volumn 311, Issue 5, 2014, Pages 463-

  Ioannidis, John P A ^a,b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD LAW SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

AGE; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CHOLESTEROL BLOOD LEVEL; CORONARY ARTERY DISEASE; DEVELOPING COUNTRY; DIABETES MELLITUS; DRUG COST; DRUG EFFICACY; DRUG MARKETING; HEART INFARCTION; HUMAN; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PREDICTION; PREVALENCE; PRIMARY PREVENTION; PRIORITY JOURNAL; RACE; SCORING SYSTEM; SEX; SHORT SURVEY; SMOKING; UNITED STATES;

ADULT; AGED; AMERICAN HEART ASSOCIATION; CARDIOVASCULAR DISEASES; CLINICAL TRIALS AS TOPIC; DEMOGRAPHY; DRUG INDUSTRY; EVIDENCE-BASED MEDICINE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERCHOLESTEROLEMIA; MIDDLE AGED; MODELS, THEORETICAL; PRACTICE GUIDELINES AS TOPIC; RISK ASSESSMENT; SOCIETIES, MEDICAL; UNITED STATES;

EID: 84893325766     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2013.284657     Document Type: Short Survey

References (9)

1. Goff DC Jr, Lloyd-Jones DM, Bennett G, et al. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines [published online November 12, 2013]. Circulation. doi:10.1161/01.cir. 0000437741.48606.98.
2. Stone NJ, Robinson J, Lichtenstein AH, et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines [published online November 12, 2013]. Circulation. doi:10.1161/01.cir.0000437738.63853.7a.
3. Ridker PM, Cook NR. Statins: new American guidelines for prevention of cardiovascular disease [published online November 20, 2013]. Lancet. doi:10.1016/S0140-6736(13)62388-0.
4. Lenzer J. Majority of panelists on controversial new cholesterol guideline have current or recent ties to drug manufacturers. BMJ. 2013;347:f6989.
5. Ajay VS, Prabhakaran D. Coronary heart disease in Indians: implications of the INTERHEART study. Indian J Med Res. 2010;132(5):561-566.
6. Siontis GC, Tzoulaki I, Siontis KC, Ioannidis JP. Comparisons of established risk prediction models for cardiovascular disease: systematic review. BMJ. 2012;344:e3318.
7. Voight BF, Peloso GM, Orho-Melander M, et al. Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study. Lancet. 2012;380(9841):572-580.
8. Lenzer J, Hoffman JR, Furberg CD, Ioannidis JP; Guideline Panel Review Working Group. Ensuring the integrity of clinical practice guidelines: a tool for protecting patients. BMJ. 2013;347:f5535.
9. Brawley O, Byers T, Chen A, et al. New American Cancer Society process for creating trustworthy cancer screening guidelines. JAMA. 2011;306(22):2495- 2499.